MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
8.82
-0.20
-2.17%
Opening 11:53 05/28 EDT
OPEN
9.08
PREV CLOSE
9.02
HIGH
9.40
LOW
8.55
VOLUME
9.88K
TURNOVER
0
52 WEEK HIGH
10.70
52 WEEK LOW
1.860
MARKET CAP
82.66M
P/E (TTM)
-0.8942
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at BNTC last week (0520-0524)?
Weekly Report · 1d ago
CureVac: Remains A Hold Based On Bird Flu Vaccine And Oncology Advancements
Seeking Alpha · 4d ago
Weekly Report: what happened at BNTC last week (0513-0517)?
Weekly Report · 05/20 11:51
Buy Rating for Benitec Biopharma on Promising Early-Stage Clinical Data and Solid Financials
TipRanks · 05/20 04:25
Benitec Biopharma files to sell 32.87M shares of common stock for holders
Healthcare Benitec Biopharma files to sell shares of common stock for holders May 16, 2024 10:21am ET. Benite c biopharma filed a prospectus related to the proposed resale of million common shares by the selling stockholders.
Seeking Alpha · 05/16 14:21
BNTC Stock Earnings: Benitec Biopharma Misses EPS for Q3 2024
Benitec Biopharma reported earnings per share of -$ for the third quarter of 2024. The company did not report any revenue for the quarter. This was below the analyst estimate for EPS of -78 cents. Benitec biopharma also reported results for the fourth quarter of 2015.
Investorplace · 05/13 18:53
FFIE, OGEN and CCLD among mid-day movers
On the Move FFIE, OGEN and CCLD among mid-day movers. CareCloud (CCLD) and Gamestop Corporation (GME) Gainers: CareCloud, Novavax and Tupperware Brands Corporation. Losers: TransCode Therapeutics and Koss Corp.
Seeking Alpha · 05/13 17:30
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers CareCloud stock moved upwards by to $ during Monday's regular session. Novavax stock rose   to $ after their, Q1 earnings came out yesterday. The company's market cap stands at $ billion. Losers TransCode Therapeutics and Applied DNA Sciences also declined.
Benzinga · 05/13 16:31
More
About BNTC
Benitec Biopharma Inc. is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines with headquarters in Hayward, California. The Company’s platform, DNA-directed RNA interference (ddRNAi), combines ribonucleic acid (RNA) interference with gene therapy to create medicines that facilitate sustained silencing of disease-causing genes following a single administration. The Company is also engaged in developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life-threatening genetic disorder. The Company's BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to permanently silence the expression of the disease-causing gene (to slow, or halt, the biological mechanisms underlying disease progression in OPMD) and to simultaneously replace the mutant gene with a wildtype gene (to drive restoration of function in diseased cells).

Webull offers Benitec Biopharma Inc stock information, including NASDAQ: BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.